Locoid Lipocream
NDC Package 0496-0821-45
Package Information
Locoid Lipocream is a medication used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash). Marketed by Ferndale Laboratories, Inc., this product is identified by NDC 0496-0821 and is authorized under FDA application NDA020769.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0496 - Ferndale Laboratories, Inc.
- 0496-0821 - Locoid Lipocream
- 0496-0821-45 - 45 g in 1 TUBE
- 0496-0821 - Locoid Lipocream
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0496-0821). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0496-0821-45 identifies a specific commercial package of 45 g in 1 tube of Locoid Lipocream, labeled by Ferndale Laboratories, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Ferndale Laboratories, Inc. on August 01, 2006. The current certification is valid through April 29, 2014.
What are the primary indications for this medication?
This medication is used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash). Hydrocortisone butyrate reduces the swelling, itching, and redness that can occur in these types of conditions. The topical solution is used to treat severe dandruff (seborrheic dermatitis). This medication is a medium-strength corticosteroid.
How is this Ferndale Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00496082145. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.